Himachal Pradesh high court restrains DRL from selling BI's diabetic drug Jardiance

The drugmaker said it is reviewing legal options including filing an appeal against the court order. Dr Reddy's has launched copies of Jardiance (empagliflozin), which has valid patent in India until 2025. BI has sought restraining order on manufacture and sale of the drug.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news